- Home
- COLM vs PTGX Comparison
COLM vs PTGX Comparison
Compare COLM & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLM
- PTGX
- Stock Information
- Founded
- COLM 1938
- PTGX 2006
- Country
- COLM United States
- PTGX United States
- Employees
- COLM N/A
- PTGX N/A
- Industry
- COLM Apparel
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- COLM Consumer Discretionary
- PTGX Health Care
- Exchange
- COLM Nasdaq
- PTGX Nasdaq
- Market Cap
- COLM 3.5B
- PTGX 2.9B
- IPO Year
- COLM 1998
- PTGX 2016
- Fundamental
- Price
- COLM $63.78
- PTGX $47.47
- Analyst Decision
- COLM Hold
- PTGX Strong Buy
- Analyst Count
- COLM 6
- PTGX 8
- Target Price
- COLM $68.00
- PTGX $66.50
- AVG Volume (30 Days)
- COLM 863.4K
- PTGX 789.1K
- Earning Date
- COLM 07-24-2025
- PTGX 05-06-2025
- Dividend Yield
- COLM 1.88%
- PTGX N/A
- EPS Growth
- COLM N/A
- PTGX N/A
- EPS
- COLM 3.88
- PTGX 0.86
- Revenue
- COLM $3,377,052,000.00
- PTGX $207,801,000.00
- Revenue This Year
- COLM $2.80
- PTGX N/A
- Revenue Next Year
- COLM $2.77
- PTGX $50.30
- P/E Ratio
- COLM $16.45
- PTGX $55.04
- Revenue Growth
- COLM N/A
- PTGX N/A
- 52 Week Low
- COLM $58.44
- PTGX $27.00
- 52 Week High
- COLM $92.88
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- COLM 43.49
- PTGX 58.60
- Support Level
- COLM $62.79
- PTGX $45.43
- Resistance Level
- COLM $66.44
- PTGX $46.80
- Average True Range (ATR)
- COLM 1.59
- PTGX 1.54
- MACD
- COLM 0.03
- PTGX 0.34
- Stochastic Oscillator
- COLM 11.14
- PTGX 94.26
About COLM Columbia Sportswear Company
Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. Columbia sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.